Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Completed
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
2003-03-01
The purpose of this study is to evaluate the pharmacokinetics (PKs) of antiretroviral (ARV)
and tuberculosis (TB) medications in pregnant women and their infants. (Pharmacokinetics are
the various interactions between a drug and the body.) This study will also evaluate the PKs
of certain ARVs in postpartum women before and after starting hormonal contraceptives. The
PKs of these drugs will be evaluated by measuring the amount of medicine present in blood
and/or vaginal secretions.
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Completed
National Institute of Allergy and Infectious Diseases (NIAID)
2003-03-01
The purpose of this study is to evaluate the pharmacokinetics (PKs) of antiretroviral (ARV)
and tuberculosis (TB) medications in pregnant women and their infants. (Pharmacokinetics are
the various interactions between a drug and the body.) This study will also evaluate the PKs
of certain ARVs in postpartum women before and after starting hormonal contraceptives. The
PKs of these drugs will be evaluated by measuring the amount of medicine present in blood
and/or vaginal secretions.
Assess the mycobactericidal activity of PA-824 (given at 200 mg daily) when added to
first-line tuberculosis (TB) treatment (isoniazid, pyrazinamide, and a rifamycin antibiotic)
over 12 weeks of treatment. Funding Source - FDA OOPD
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
